Navigation Links
Transdel Pharmaceuticals Announces Management Reorganization
Date:2/18/2010

from the Phase 3 clinical trial may vary from the Company's initial conclusions; the FDA may not agree with the Company's interpretation of such results or may challenge the adequacy of the Company's clinical trial design or the execution of the clinical trial; the FDA may continue to require the Company to complete additional clinical trials for Ketotransdel® before the Company can submit a 505(b)2 NDA application; the results of any future clinical trials may not be favorable and the Company may never receive regulatory approval for Ketotransdel®; and the Company's current need to raise additional funding to complete its product development plans. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q filed with the SEC. Such documents may be read free of charge on the SEC's web site at www.sec.gov. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement and the Company undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

SOURCE Transdel Pharmaceuticals, Inc.

RELATED LINKS
http://www.transdelpharma.com

'/>"/>

SOURCE Transdel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Transdel Pharmaceuticals to Webcast Presentation at 4th Annual BIOCOM Investor Conference
2. Transdel Enrolls First Patient for Ketotransdel(TM) Phase 3 Clinical Trial
3. Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
4. Transdel Pharmaceuticals Advances Lead Topical Pain Drug into Phase 3 Program
5. Merz Pharmaceuticals Introduces New Mederma(R) Stretch Marks Therapy Now Available in Drugstores Nationwide
6. GlaxoSmithKline President of North America Pharmaceuticals, Deirdre Connelly, Named 2010 Woman of the Year by the Healthcare Businesswomens Association
7. Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.
8. Alexza Pharmaceuticals to Host 2010 Investor/Analyst Day on Thursday, February 18, 2010
9. Endo Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on February 22, 2010
10. Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma
11. ISTA Pharmaceuticals Announces 2010 Financial Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , 7 de julio de 2015 /PRNewswire/ ... de propiedad privada centrada en el desarrollo de ... neurovascular, ha anunciado hoy que R. Michael ... directiva. Kleine cuenta con más ... de los dispositivos médicos y la sanidad. Ha ...
(Date:7/7/2015)... , July 7, 2015 According ... by Method (Manual, Automated), Product (Consumables, Instrument), Application (Aerobic, Anaerobic, ... Academic Research Institute) - Forecast to 2019", published by MarketsandMarkets, ... $3,893.5 Million by 2019 from $2,750.2 Million in 2014 at ... 1 78 ma rket ...
(Date:7/7/2015)... Md. , July 7, 2015 ... (CRO) focusing in Oncology, Vaccines, and General Medicine ... the final locked database to Heron Therapeutics, Inc. ... 3 receptor antagonist product candidate SUSTOL® (granisetron ... regimen with the IV NK 1 receptor ...
Breaking Medicine Technology:Sequent Medical nombra a Mike Kleine a su junta directiva 2Sequent Medical nombra a Mike Kleine a su junta directiva 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 2Blood Culture Tests Market Worth $3,893.5 Million by 2019 3Blood Culture Tests Market Worth $3,893.5 Million by 2019 4Accelovance Completes Trial Enrollment and Delivery of Clinical Data for Heron Therapeutics' Phase 3 Trial 2
... Supreme Court decision in Pliva v. Mensing is ... legal immunity when they ignore harmful side-effects of the drugs ... for generic manufacturers to ensure their drug is safe and ... This decision also means that brand-name manufacturers will be held ...
... Ill., June 23, 2011 Akorn, Inc. (NASDAQ: ... Tuesday, August 2, 2011, to discuss second quarter 2011 ... the same day before the market opens. Subject: , ... 2, 2011, at 10:00 a.m. Eastern TimeDomestic Callers: , ...
Cached Medicine Technology:Generic Drug Decision Disastrous to Patient Safety 2
(Date:7/7/2015)... ... July 07, 2015 , ... The United States Centers ... Committee of Massachusetts , and the Multicultural AIDS Coalition $3.78 million for ... who have sex with men (MSM) and transgender women, the groups at highest ...
(Date:7/7/2015)... ... July 07, 2015 , ... Celestix Networks, the leading ... CelestixFederated VA Series virtual appliances. These virtual platforms expand the existing physical ... have proven to simplify the on-premises deployment of unified remote access and single ...
(Date:7/7/2015)... , ... July 07, 2015 , ... ... industry group whose board is limited to permit holders. The Medical Cannabis Alliance ... to move the industry forward and are committed to making sure patients have ...
(Date:7/7/2015)... (PRWEB) , ... July 07, ... ... the leading global provider of advanced delivery technologies and development solutions for ... an exclusive licensing agreement with Excelimmune, Inc. to access its antibody combination ...
(Date:7/7/2015)... ... ... Safe Catch is setting revolutionary purity limits for canned tuna as the only ... Markets, Sprouts Farmers Market and Wegmans are some of the first grocers to stock ... mercury,” said Safe Catch co-founder Sean Wittenberg. “We launched Safe Catch tuna for health ...
Breaking Medicine News(10 mins):Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 2Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 3Health News:Celestix Now Offers Virtual Editions of Its Unified Remote Access and SSO Platforms to Enable Easy Deployment in Virtualized Environments 4Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2
... more easily when they figure out the words' meaning for ... ,Meredith Brinster, an undergraduate student in the John ... found that learning words by inference is more powerful for ... ,"One of the things that is particularly exciting about the ...
... the state children’s health insurance program (SCHIP), teens ... eliminated and more preventive care is received. This ... their health care providers about guns, smoking, drugs, ... their long-term health. ,"Adolescents have the ...
... function and increases spontaneous pain in women//. This supports ... pain, according to a study published in the April ... conducted by Michael T. Smith, PhD, and colleagues at ... were studied polysomnographically for seven nights. On the first ...
... a type of bacteria found in soil boosts happiness levels ... are depressed and prone to infection, says a study. ... treated lung cancer patients with the bacteria, named 'bacterium Mycobacterium ... the online edition of BBC News. ,However, ...
... decided to take the hospital from which her late husband caught ... Burton-Pye, 67, said she would speak to a lawyer about the ... at the James Paget University Hospital in Gorleston, Norfolk. ... transfusion almost a month back, when all the while ...
... nothing like getting down and dirty say researchers from Bristol ... ,The study led by Dr. Chris Lowry and ... actually replicate the effects of anti- depressant drugs. ... cancer patients who were treated with the bacteria. They reported ...
Cached Medicine News:Health News:Learning Words by Inference More Powerful for Toddlers 2Health News:Teens Get Needed Access to Care With State Health Insurance 2Health News:Teens Get Needed Access to Care With State Health Insurance 3Health News:New Study in SLEEP Finds That Sleep Disturbance Increases Spontaneous Pain in Women 2Health News:Be Happy- Get On Your Knees And Play In The Mud 2
... immunofluorescent antibody (IFA) test ... semi-quantitation of human serum ... viral capsid antigen (VCA). ... 12-well slides, FITC IgG ...
CMF OL1000 Bone Growth Stimulators are portable, battery-powered medical devices indicated for use in the noninvasive treatment of an established nonunion fracture acquired secondary to trauma, exclu...
... bone growth stimulator for the treatment of ... bone growth stimulator is a useful adjunct ... is already planned or when patient compliance ... is totally surgically implanted, patients are assured ...
... Stryker is proud to ... resectoscopes on the market at ... ergonomic design incorporates a superior ... and intuitive locking mechanisms. The ...
Medicine Products: